LM22B-10 is primarily researched for its potential therapeutic applications in neurodegenerative diseases. It functions as a small molecule activator of the TrkB receptor, which plays a critical role in promoting neuronal survival, growth, and synaptic plasticity. This makes it a promising candidate for treating conditions such as Alzheimer's disease, Parkinson's disease, and other forms of dementia. Additionally, LM22B-10 has shown potential in aiding recovery from brain injuries by enhancing neurogenesis and reducing neuronal damage. Its ability to modulate neurotrophic signaling pathways also suggests applications in mitigating cognitive decline and improving memory function in aging populations. Further studies are ongoing to explore its efficacy and safety in clinical settings.